Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Death, Sudden, Cardiac | 76 | 2021 | 1568 | 7.370 |
Why?
|
Defibrillators, Implantable | 75 | 2024 | 1498 | 6.430 |
Why?
|
Tachycardia, Ventricular | 52 | 2024 | 1309 | 4.780 |
Why?
|
Tachycardia | 68 | 2014 | 599 | 2.460 |
Why?
|
Electrophysiologic Techniques, Cardiac | 23 | 2024 | 511 | 2.010 |
Why?
|
Anti-Arrhythmia Agents | 42 | 2020 | 775 | 1.890 |
Why?
|
Primary Prevention | 18 | 2020 | 1187 | 1.780 |
Why?
|
Heart Conduction System | 30 | 2021 | 1009 | 1.750 |
Why?
|
Ventricular Dysfunction, Left | 21 | 2020 | 2145 | 1.700 |
Why?
|
Cardiac Pacing, Artificial | 63 | 2019 | 881 | 1.690 |
Why?
|
Arrhythmias, Cardiac | 46 | 2020 | 2258 | 1.650 |
Why?
|
Electrocardiography | 90 | 2024 | 6413 | 1.580 |
Why?
|
Catheter Ablation | 27 | 2024 | 2780 | 1.570 |
Why?
|
Ventricular Fibrillation | 19 | 2018 | 537 | 1.570 |
Why?
|
Stroke Volume | 38 | 2024 | 5622 | 1.540 |
Why?
|
Electric Countershock | 27 | 2019 | 534 | 1.540 |
Why?
|
Myocardial Infarction | 40 | 2019 | 11521 | 1.010 |
Why?
|
Coronary Disease | 36 | 2013 | 5919 | 0.890 |
Why?
|
Tachycardia, Supraventricular | 8 | 2018 | 273 | 0.870 |
Why?
|
Heart Ventricles | 40 | 2024 | 3840 | 0.860 |
Why?
|
Atrial Flutter | 8 | 2015 | 253 | 0.780 |
Why?
|
Heart Atria | 11 | 2018 | 1361 | 0.740 |
Why?
|
Cardiac Electrophysiology | 2 | 2018 | 60 | 0.710 |
Why?
|
Risk Assessment | 34 | 2020 | 24333 | 0.710 |
Why?
|
Heart Rate | 16 | 2021 | 4217 | 0.710 |
Why?
|
Electrophysiology | 49 | 2023 | 1266 | 0.700 |
Why?
|
Heart Failure | 29 | 2019 | 11879 | 0.680 |
Why?
|
Atrial Fibrillation | 21 | 2019 | 5176 | 0.650 |
Why?
|
Natriuretic Peptide, Brain | 2 | 2020 | 1751 | 0.630 |
Why?
|
Ventricular Function, Left | 11 | 2024 | 3941 | 0.590 |
Why?
|
Tachycardia, Atrioventricular Nodal Reentry | 5 | 2021 | 148 | 0.580 |
Why?
|
Cicatrix | 5 | 2024 | 799 | 0.510 |
Why?
|
Ventricular Premature Complexes | 5 | 2019 | 112 | 0.510 |
Why?
|
Peptide Fragments | 2 | 2020 | 5151 | 0.480 |
Why?
|
Action Potentials | 6 | 2020 | 1838 | 0.460 |
Why?
|
Endocardium | 13 | 2019 | 249 | 0.450 |
Why?
|
Electrocardiography, Ambulatory | 5 | 2010 | 582 | 0.450 |
Why?
|
Coronary Artery Disease | 11 | 2015 | 6569 | 0.440 |
Why?
|
Procainamide | 12 | 1993 | 56 | 0.440 |
Why?
|
Pulmonary Veins | 5 | 2018 | 758 | 0.430 |
Why?
|
Heart Arrest | 24 | 2015 | 1515 | 0.430 |
Why?
|
Practice Guidelines as Topic | 10 | 2018 | 7460 | 0.420 |
Why?
|
Signal Processing, Computer-Assisted | 3 | 2018 | 1495 | 0.420 |
Why?
|
Proportional Hazards Models | 17 | 2017 | 12562 | 0.420 |
Why?
|
Kidney Function Tests | 1 | 2015 | 684 | 0.410 |
Why?
|
Diagnostic Techniques, Cardiovascular | 3 | 2011 | 153 | 0.400 |
Why?
|
Cardiology | 9 | 2020 | 1701 | 0.380 |
Why?
|
Humans | 265 | 2024 | 768970 | 0.380 |
Why?
|
Death, Sudden | 15 | 2005 | 301 | 0.370 |
Why?
|
Randomized Controlled Trials as Topic | 21 | 2019 | 10400 | 0.360 |
Why?
|
Echocardiography | 7 | 2018 | 5047 | 0.360 |
Why?
|
Adrenergic beta-Antagonists | 8 | 2017 | 1243 | 0.350 |
Why?
|
Prosthesis Implantation | 1 | 2015 | 594 | 0.350 |
Why?
|
Myocardial Ischemia | 3 | 2018 | 2139 | 0.350 |
Why?
|
Biometry | 1 | 2013 | 570 | 0.340 |
Why?
|
Cardiac Resynchronization Therapy | 1 | 2015 | 560 | 0.330 |
Why?
|
Heart Diseases | 11 | 2023 | 2819 | 0.320 |
Why?
|
Patient Selection | 6 | 2019 | 4265 | 0.320 |
Why?
|
Aged | 117 | 2024 | 171786 | 0.310 |
Why?
|
Treatment Outcome | 38 | 2023 | 65480 | 0.310 |
Why?
|
Middle Aged | 139 | 2024 | 223737 | 0.300 |
Why?
|
Male | 147 | 2024 | 365203 | 0.290 |
Why?
|
Therapeutic Irrigation | 2 | 2019 | 297 | 0.290 |
Why?
|
American Heart Association | 8 | 2023 | 1051 | 0.290 |
Why?
|
Risk Factors | 43 | 2023 | 74976 | 0.290 |
Why?
|
Amiodarone | 13 | 2008 | 217 | 0.280 |
Why?
|
Glomerular Filtration Rate | 2 | 2015 | 2228 | 0.270 |
Why?
|
Device Removal | 3 | 2018 | 643 | 0.270 |
Why?
|
Torsades de Pointes | 2 | 2020 | 78 | 0.270 |
Why?
|
Heart | 17 | 2021 | 4447 | 0.270 |
Why?
|
Female | 144 | 2024 | 397515 | 0.260 |
Why?
|
Hypertrophy, Left Ventricular | 2 | 2011 | 856 | 0.260 |
Why?
|
Electrodiagnosis | 3 | 2016 | 149 | 0.250 |
Why?
|
Prognosis | 27 | 2020 | 30046 | 0.250 |
Why?
|
Prosthesis Failure | 5 | 2019 | 1209 | 0.240 |
Why?
|
Bundle-Branch Block | 12 | 2015 | 278 | 0.240 |
Why?
|
Multicenter Studies as Topic | 6 | 2017 | 1737 | 0.240 |
Why?
|
Swine | 9 | 2019 | 5997 | 0.230 |
Why?
|
Societies, Medical | 7 | 2020 | 3968 | 0.230 |
Why?
|
Models, Statistical | 2 | 2016 | 5110 | 0.230 |
Why?
|
Equipment Failure | 5 | 2020 | 585 | 0.230 |
Why?
|
Follow-Up Studies | 35 | 2024 | 39394 | 0.220 |
Why?
|
Survival Rate | 14 | 2018 | 12873 | 0.220 |
Why?
|
Cardiomyopathies | 10 | 2018 | 2057 | 0.220 |
Why?
|
Atrioventricular Node | 10 | 2021 | 180 | 0.220 |
Why?
|
Time Factors | 40 | 2020 | 40261 | 0.220 |
Why?
|
Sleep Apnea, Obstructive | 3 | 2017 | 1899 | 0.210 |
Why?
|
Autonomic Nervous System | 3 | 2016 | 709 | 0.210 |
Why?
|
Predictive Value of Tests | 12 | 2018 | 15471 | 0.210 |
Why?
|
Cardiomyopathy, Hypertrophic | 5 | 2015 | 1335 | 0.200 |
Why?
|
Cause of Death | 5 | 2019 | 3721 | 0.190 |
Why?
|
Prospective Studies | 27 | 2020 | 54962 | 0.190 |
Why?
|
Biomedical Research | 1 | 2017 | 3463 | 0.190 |
Why?
|
Mitral Valve Prolapse | 2 | 2000 | 213 | 0.190 |
Why?
|
Evidence-Based Medicine | 1 | 2013 | 3709 | 0.180 |
Why?
|
Isoproterenol | 4 | 1997 | 398 | 0.180 |
Why?
|
Data Collection | 2 | 2006 | 3324 | 0.180 |
Why?
|
Coronary Artery Bypass | 5 | 2002 | 2194 | 0.170 |
Why?
|
United States | 32 | 2023 | 73186 | 0.170 |
Why?
|
Cardiomyopathy, Dilated | 6 | 2000 | 843 | 0.170 |
Why?
|
Survivors | 1 | 2010 | 2383 | 0.170 |
Why?
|
Electric Injuries | 1 | 2019 | 24 | 0.170 |
Why?
|
Recurrence | 16 | 2024 | 8513 | 0.160 |
Why?
|
Body Surface Potential Mapping | 3 | 2019 | 228 | 0.160 |
Why?
|
Decision Support Techniques | 3 | 2019 | 2008 | 0.160 |
Why?
|
Retrospective Studies | 25 | 2024 | 81903 | 0.160 |
Why?
|
Medicare | 2 | 2018 | 6888 | 0.150 |
Why?
|
Defibrillators | 1 | 2018 | 39 | 0.150 |
Why?
|
Belgium | 1 | 2018 | 119 | 0.150 |
Why?
|
Verapamil | 5 | 1987 | 242 | 0.150 |
Why?
|
Ventricular Function | 3 | 1997 | 406 | 0.150 |
Why?
|
Ventricular Remodeling | 2 | 2016 | 1282 | 0.150 |
Why?
|
Bradycardia | 4 | 2009 | 305 | 0.150 |
Why?
|
Fraud | 1 | 2018 | 66 | 0.150 |
Why?
|
Myocardial Contraction | 4 | 2018 | 1526 | 0.150 |
Why?
|
Electroshock | 1 | 2017 | 120 | 0.140 |
Why?
|
Probability | 2 | 2016 | 2483 | 0.140 |
Why?
|
Advisory Committees | 2 | 2011 | 797 | 0.140 |
Why?
|
Myocardial Revascularization | 2 | 2018 | 796 | 0.130 |
Why?
|
Atherosclerosis | 3 | 2018 | 3431 | 0.130 |
Why?
|
Catheters | 1 | 2019 | 427 | 0.130 |
Why?
|
Cardiovascular Diseases | 10 | 2023 | 15661 | 0.130 |
Why?
|
Protein Precursors | 1 | 2020 | 1135 | 0.130 |
Why?
|
Aged, 80 and over | 14 | 2019 | 59739 | 0.130 |
Why?
|
Heart Function Tests | 4 | 2014 | 317 | 0.130 |
Why?
|
Cardiac Complexes, Premature | 2 | 1992 | 63 | 0.120 |
Why?
|
Insurance Coverage | 2 | 2018 | 1946 | 0.120 |
Why?
|
Tachycardia, Paroxysmal | 2 | 2014 | 30 | 0.120 |
Why?
|
Thermometers | 1 | 2015 | 42 | 0.120 |
Why?
|
Heart Valve Prosthesis | 1 | 2023 | 1468 | 0.120 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 2 | 2019 | 325 | 0.120 |
Why?
|
Sympathetic Nervous System | 2 | 2015 | 521 | 0.120 |
Why?
|
Clinical Trials as Topic | 8 | 2017 | 8055 | 0.110 |
Why?
|
Ablation Techniques | 1 | 2017 | 255 | 0.110 |
Why?
|
Survival Analysis | 8 | 2014 | 10115 | 0.110 |
Why?
|
Syncope | 6 | 2014 | 430 | 0.110 |
Why?
|
Comorbidity | 9 | 2018 | 10592 | 0.110 |
Why?
|
Therapeutic Equipoise | 1 | 2013 | 29 | 0.110 |
Why?
|
Risk | 16 | 2014 | 9621 | 0.110 |
Why?
|
Myocardium | 3 | 2019 | 4790 | 0.110 |
Why?
|
Consensus | 2 | 2020 | 3214 | 0.110 |
Why?
|
Chi-Square Distribution | 4 | 2016 | 3438 | 0.110 |
Why?
|
Sinoatrial Node | 6 | 2007 | 99 | 0.100 |
Why?
|
Out-of-Hospital Cardiac Arrest | 1 | 2017 | 340 | 0.100 |
Why?
|
North America | 1 | 2016 | 1290 | 0.100 |
Why?
|
Stellate Ganglion | 1 | 2012 | 51 | 0.100 |
Why?
|
Affect | 2 | 2021 | 1500 | 0.100 |
Why?
|
Equipment Design | 4 | 2019 | 3530 | 0.100 |
Why?
|
Baroreflex | 2 | 2011 | 154 | 0.100 |
Why?
|
Computer Simulation | 3 | 2016 | 6291 | 0.100 |
Why?
|
Heart Failure, Systolic | 1 | 2014 | 134 | 0.100 |
Why?
|
Sympathectomy | 1 | 2012 | 72 | 0.100 |
Why?
|
Diffusion of Innovation | 1 | 2017 | 732 | 0.100 |
Why?
|
Takotsubo Cardiomyopathy | 1 | 2014 | 125 | 0.100 |
Why?
|
Research Support as Topic | 1 | 1996 | 696 | 0.100 |
Why?
|
Diagnosis, Computer-Assisted | 2 | 2015 | 709 | 0.100 |
Why?
|
Electrocoagulation | 2 | 1989 | 157 | 0.100 |
Why?
|
Vectorcardiography | 2 | 2024 | 48 | 0.100 |
Why?
|
Kaplan-Meier Estimate | 7 | 2017 | 6547 | 0.090 |
Why?
|
Health Services | 1 | 1996 | 755 | 0.090 |
Why?
|
Atrial Septum | 1 | 2011 | 61 | 0.090 |
Why?
|
Alloys | 1 | 2011 | 111 | 0.090 |
Why?
|
Bayes Theorem | 2 | 2016 | 2360 | 0.090 |
Why?
|
Aortic Valve Stenosis | 1 | 2023 | 2034 | 0.090 |
Why?
|
History, 21st Century | 1 | 2017 | 1575 | 0.090 |
Why?
|
Vocabulary | 1 | 2011 | 167 | 0.090 |
Why?
|
Atrial Appendage | 1 | 2014 | 285 | 0.090 |
Why?
|
Health Behavior | 1 | 2022 | 2649 | 0.090 |
Why?
|
Congresses as Topic | 1 | 2015 | 812 | 0.090 |
Why?
|
Stroke | 2 | 2023 | 9756 | 0.090 |
Why?
|
Punctures | 1 | 2011 | 372 | 0.080 |
Why?
|
Evaluation Studies as Topic | 2 | 2011 | 1629 | 0.080 |
Why?
|
Electric Stimulation | 11 | 2004 | 1742 | 0.080 |
Why?
|
Cost of Illness | 1 | 2019 | 1960 | 0.080 |
Why?
|
Disease Management | 1 | 2020 | 2537 | 0.080 |
Why?
|
History, 20th Century | 1 | 2017 | 2771 | 0.080 |
Why?
|
Incidence | 9 | 2020 | 21547 | 0.080 |
Why?
|
Latin America | 2 | 2020 | 416 | 0.080 |
Why?
|
Esophagus | 1 | 2015 | 1043 | 0.080 |
Why?
|
Terminology as Topic | 4 | 2011 | 1541 | 0.080 |
Why?
|
Algorithms | 5 | 2018 | 14201 | 0.080 |
Why?
|
Propranolol | 4 | 1984 | 493 | 0.080 |
Why?
|
Decision Making | 2 | 2013 | 3953 | 0.080 |
Why?
|
Asia | 2 | 2020 | 630 | 0.080 |
Why?
|
Monitoring, Intraoperative | 1 | 2015 | 950 | 0.080 |
Why?
|
Organotechnetium Compounds | 1 | 2008 | 133 | 0.080 |
Why?
|
Chest Pain | 1 | 2015 | 1101 | 0.080 |
Why?
|
Continuous Positive Airway Pressure | 1 | 2013 | 580 | 0.070 |
Why?
|
3-Iodobenzylguanidine | 1 | 2008 | 115 | 0.070 |
Why?
|
Patient-Centered Care | 2 | 2019 | 1447 | 0.070 |
Why?
|
Body Height | 1 | 2013 | 1569 | 0.070 |
Why?
|
Organophosphorus Compounds | 1 | 2008 | 211 | 0.070 |
Why?
|
Refractory Period, Electrophysiological | 4 | 1997 | 40 | 0.070 |
Why?
|
Adult | 64 | 2017 | 223851 | 0.070 |
Why?
|
Prevalence | 3 | 2016 | 15879 | 0.070 |
Why?
|
Minnesota | 2 | 2018 | 339 | 0.070 |
Why?
|
Sensitivity and Specificity | 4 | 2007 | 14752 | 0.070 |
Why?
|
Confidence Intervals | 2 | 2014 | 2932 | 0.070 |
Why?
|
Injections, Intravenous | 8 | 2010 | 1379 | 0.070 |
Why?
|
Bundle of His | 3 | 2021 | 102 | 0.060 |
Why?
|
Europe | 3 | 2020 | 3441 | 0.060 |
Why?
|
Registries | 5 | 2016 | 8384 | 0.060 |
Why?
|
Positron-Emission Tomography | 2 | 2015 | 6673 | 0.060 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 4 | 2011 | 1514 | 0.060 |
Why?
|
Ventricular Dysfunction | 1 | 2006 | 144 | 0.060 |
Why?
|
Nitroglycerin | 3 | 1982 | 332 | 0.060 |
Why?
|
Sus scrofa | 2 | 2018 | 430 | 0.060 |
Why?
|
Hypotension | 3 | 1987 | 888 | 0.060 |
Why?
|
Animals | 13 | 2019 | 169335 | 0.060 |
Why?
|
Monitoring, Physiologic | 8 | 1988 | 1798 | 0.060 |
Why?
|
Unconsciousness | 1 | 1987 | 251 | 0.060 |
Why?
|
Quinidine | 4 | 1991 | 52 | 0.060 |
Why?
|
Medical Records Systems, Computerized | 1 | 2011 | 1196 | 0.060 |
Why?
|
Exercise | 1 | 2022 | 5954 | 0.060 |
Why?
|
Heart Transplantation | 2 | 1996 | 3301 | 0.060 |
Why?
|
Polysomnography | 2 | 2013 | 1871 | 0.060 |
Why?
|
Long QT Syndrome | 1 | 2009 | 472 | 0.060 |
Why?
|
Ergonovine | 2 | 1982 | 14 | 0.060 |
Why?
|
Iodine Radioisotopes | 1 | 2008 | 1034 | 0.060 |
Why?
|
Electric Impedance | 2 | 2019 | 795 | 0.060 |
Why?
|
Acute Disease | 3 | 2012 | 7245 | 0.060 |
Why?
|
Oximetry | 1 | 2007 | 462 | 0.060 |
Why?
|
Feasibility Studies | 2 | 2023 | 5323 | 0.060 |
Why?
|
Reproducibility of Results | 3 | 2018 | 20245 | 0.060 |
Why?
|
Quality Assurance, Health Care | 2 | 2011 | 2182 | 0.050 |
Why?
|
Muscle, Skeletal | 1 | 2018 | 4978 | 0.050 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2008 | 1141 | 0.050 |
Why?
|
Family Practice | 1 | 1985 | 509 | 0.050 |
Why?
|
Disease Models, Animal | 5 | 2019 | 18354 | 0.050 |
Why?
|
Microcirculation | 1 | 2007 | 1281 | 0.050 |
Why?
|
Coronary Vasospasm | 1 | 1982 | 81 | 0.050 |
Why?
|
Pilot Projects | 2 | 2023 | 8748 | 0.050 |
Why?
|
Postoperative Complications | 6 | 2014 | 15889 | 0.050 |
Why?
|
Dogs | 1 | 2007 | 3845 | 0.050 |
Why?
|
Forecasting | 4 | 2014 | 2945 | 0.050 |
Why?
|
Pacemaker, Artificial | 5 | 2010 | 828 | 0.050 |
Why?
|
Angina Pectoris, Variant | 1 | 1981 | 53 | 0.050 |
Why?
|
Appointments and Schedules | 1 | 1985 | 443 | 0.050 |
Why?
|
Guideline Adherence | 1 | 2011 | 2241 | 0.050 |
Why?
|
Drug Evaluation | 4 | 1993 | 642 | 0.050 |
Why?
|
Referral and Consultation | 1 | 2014 | 3628 | 0.050 |
Why?
|
Fluoroquinolones | 1 | 2003 | 309 | 0.040 |
Why?
|
Canada | 2 | 2002 | 2130 | 0.040 |
Why?
|
Diagnosis, Differential | 5 | 2015 | 13021 | 0.040 |
Why?
|
Infusions, Parenteral | 2 | 1984 | 396 | 0.040 |
Why?
|
Clinical Competence | 3 | 2001 | 4860 | 0.040 |
Why?
|
Spasm | 1 | 1980 | 131 | 0.040 |
Why?
|
Databases, Factual | 2 | 2018 | 8094 | 0.040 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2014 | 2297 | 0.040 |
Why?
|
Diabetes Mellitus | 1 | 2018 | 5892 | 0.040 |
Why?
|
Boston | 3 | 2018 | 9377 | 0.040 |
Why?
|
Quality of Health Care | 2 | 2011 | 4339 | 0.040 |
Why?
|
Angina Pectoris | 2 | 1994 | 957 | 0.040 |
Why?
|
Severity of Illness Index | 3 | 2017 | 15951 | 0.040 |
Why?
|
Steam | 1 | 2018 | 33 | 0.040 |
Why?
|
Disposable Equipment | 1 | 1978 | 46 | 0.040 |
Why?
|
Mitral Valve Stenosis | 1 | 2001 | 342 | 0.040 |
Why?
|
United States Government Agencies | 1 | 2018 | 26 | 0.040 |
Why?
|
Prosthesis Design | 3 | 2013 | 2126 | 0.040 |
Why?
|
Genome-Wide Association Study | 1 | 2018 | 12801 | 0.040 |
Why?
|
Radiopharmaceuticals | 1 | 2008 | 2734 | 0.040 |
Why?
|
Multivariate Analysis | 3 | 2016 | 12095 | 0.040 |
Why?
|
Republic of Korea | 1 | 2020 | 592 | 0.040 |
Why?
|
Drug Contamination | 1 | 1979 | 151 | 0.040 |
Why?
|
Disease-Free Survival | 3 | 2017 | 6856 | 0.040 |
Why?
|
Retreatment | 1 | 2019 | 600 | 0.040 |
Why?
|
Acinetobacter Infections | 1 | 1978 | 73 | 0.040 |
Why?
|
Exercise Test | 4 | 2006 | 2187 | 0.040 |
Why?
|
Dextrocardia | 1 | 1976 | 37 | 0.030 |
Why?
|
Peritoneal Dialysis | 1 | 1978 | 160 | 0.030 |
Why?
|
Regression Analysis | 3 | 2014 | 6346 | 0.030 |
Why?
|
Infusions, Intra-Arterial | 2 | 1991 | 221 | 0.030 |
Why?
|
Recovery of Function | 2 | 2018 | 2990 | 0.030 |
Why?
|
Education | 1 | 2019 | 533 | 0.030 |
Why?
|
Enterobacteriaceae Infections | 1 | 1978 | 190 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 3 | 2014 | 36854 | 0.030 |
Why?
|
Patient Readmission | 3 | 2015 | 3313 | 0.030 |
Why?
|
Coronary Vessels | 4 | 1988 | 3124 | 0.030 |
Why?
|
Flecainide | 1 | 1996 | 41 | 0.030 |
Why?
|
Tricuspid Valve | 1 | 1999 | 419 | 0.030 |
Why?
|
Logistic Models | 3 | 2015 | 13318 | 0.030 |
Why?
|
Heart Septum | 1 | 1976 | 304 | 0.030 |
Why?
|
Anti-Infective Agents | 1 | 2003 | 984 | 0.030 |
Why?
|
Linear Models | 2 | 2016 | 5891 | 0.030 |
Why?
|
Heart Valve Diseases | 2 | 1999 | 1030 | 0.030 |
Why?
|
Sex Characteristics | 2 | 1999 | 2649 | 0.030 |
Why?
|
Morbidity | 1 | 2020 | 1757 | 0.030 |
Why?
|
New York | 1 | 2017 | 884 | 0.030 |
Why?
|
Economic Competition | 1 | 1996 | 223 | 0.030 |
Why?
|
Necrosis | 1 | 2018 | 1620 | 0.030 |
Why?
|
Indiana | 1 | 2014 | 93 | 0.030 |
Why?
|
Disease Progression | 3 | 2018 | 13674 | 0.030 |
Why?
|
Research Design | 2 | 2016 | 6214 | 0.030 |
Why?
|
Hospitalization | 4 | 2013 | 10847 | 0.030 |
Why?
|
Cardiomegaly | 1 | 1976 | 591 | 0.030 |
Why?
|
Cardiac Output, Low | 2 | 2006 | 192 | 0.030 |
Why?
|
Systole | 1 | 2016 | 937 | 0.030 |
Why?
|
Electronic Health Records | 1 | 2011 | 4879 | 0.030 |
Why?
|
Aortic Valve | 1 | 2023 | 1969 | 0.030 |
Why?
|
Benzofurans | 2 | 1985 | 139 | 0.030 |
Why?
|
Temperature | 1 | 2019 | 2235 | 0.030 |
Why?
|
Munchausen Syndrome | 1 | 1972 | 19 | 0.030 |
Why?
|
Heart Block | 3 | 1984 | 390 | 0.030 |
Why?
|
Pulmonary Edema | 1 | 2015 | 409 | 0.030 |
Why?
|
Syndrome | 1 | 1999 | 3274 | 0.030 |
Why?
|
Endoscopy, Digestive System | 1 | 2015 | 358 | 0.020 |
Why?
|
Cross Infection | 2 | 1979 | 1425 | 0.020 |
Why?
|
Diuretics | 1 | 2015 | 614 | 0.020 |
Why?
|
Decision Trees | 1 | 2014 | 509 | 0.020 |
Why?
|
Models, Animal | 1 | 2018 | 2122 | 0.020 |
Why?
|
Single-Blind Method | 2 | 2007 | 1586 | 0.020 |
Why?
|
Health Services Research | 1 | 2019 | 1818 | 0.020 |
Why?
|
Chronic Disease | 2 | 2002 | 9384 | 0.020 |
Why?
|
Psychotherapy | 1 | 2021 | 1654 | 0.020 |
Why?
|
Age Factors | 4 | 2015 | 18435 | 0.020 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2014 | 268 | 0.020 |
Why?
|
Electric Power Supplies | 1 | 2012 | 96 | 0.020 |
Why?
|
Life Expectancy | 1 | 2018 | 1249 | 0.020 |
Why?
|
Foundations | 1 | 2011 | 96 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 2019 | 1672 | 0.020 |
Why?
|
Cohort Studies | 4 | 2015 | 41808 | 0.020 |
Why?
|
Troponin | 1 | 2014 | 535 | 0.020 |
Why?
|
Quality of Life | 3 | 2019 | 13510 | 0.020 |
Why?
|
Radiography | 2 | 2015 | 6991 | 0.020 |
Why?
|
Health Planning Guidelines | 1 | 2010 | 153 | 0.020 |
Why?
|
Jervell-Lange Nielsen Syndrome | 1 | 2009 | 4 | 0.020 |
Why?
|
Ether-A-Go-Go Potassium Channels | 1 | 2009 | 72 | 0.020 |
Why?
|
Epicardial Mapping | 1 | 2009 | 58 | 0.020 |
Why?
|
Disease Outbreaks | 2 | 1978 | 1761 | 0.020 |
Why?
|
Differential Threshold | 1 | 1989 | 80 | 0.020 |
Why?
|
Postoperative Period | 1 | 2014 | 1830 | 0.020 |
Why?
|
Neural Conduction | 1 | 2010 | 443 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2014 | 1194 | 0.020 |
Why?
|
Digitalis Glycosides | 1 | 2008 | 47 | 0.020 |
Why?
|
Genetic Loci | 1 | 2018 | 2630 | 0.020 |
Why?
|
Stochastic Processes | 1 | 2010 | 360 | 0.020 |
Why?
|
Procaine | 1 | 1988 | 60 | 0.020 |
Why?
|
Sex Factors | 3 | 2007 | 10633 | 0.020 |
Why?
|
Echocardiography, Transesophageal | 1 | 2014 | 1096 | 0.020 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2015 | 1092 | 0.020 |
Why?
|
Combined Modality Therapy | 3 | 2009 | 8559 | 0.020 |
Why?
|
Genetic Testing | 2 | 2014 | 3591 | 0.020 |
Why?
|
Sepsis | 2 | 1979 | 2610 | 0.020 |
Why?
|
Clinical Protocols | 1 | 1993 | 1445 | 0.020 |
Why?
|
Electrophysiological Phenomena | 1 | 2009 | 310 | 0.020 |
Why?
|
Laboratories | 1 | 2011 | 463 | 0.020 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 1994 | 1724 | 0.020 |
Why?
|
Lidocaine | 2 | 1988 | 546 | 0.020 |
Why?
|
Fluoroscopy | 1 | 2011 | 947 | 0.020 |
Why?
|
Patient Satisfaction | 2 | 2012 | 3492 | 0.020 |
Why?
|
Adolescent | 16 | 1996 | 89244 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2018 | 26395 | 0.020 |
Why?
|
Phenotype | 2 | 2018 | 16731 | 0.020 |
Why?
|
Disopyramide | 2 | 1983 | 16 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 1997 | 10765 | 0.020 |
Why?
|
Markov Chains | 1 | 2010 | 979 | 0.020 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2014 | 997 | 0.020 |
Why?
|
Propanolamines | 2 | 1983 | 164 | 0.020 |
Why?
|
Goals | 1 | 2011 | 717 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2010 | 2231 | 0.020 |
Why?
|
Heart Aneurysm | 2 | 1982 | 114 | 0.020 |
Why?
|
Propensity Score | 1 | 2013 | 1968 | 0.020 |
Why?
|
Health Status | 1 | 2018 | 4095 | 0.020 |
Why?
|
London | 1 | 1985 | 233 | 0.020 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2011 | 1064 | 0.010 |
Why?
|
Cardiovascular System | 1 | 2012 | 841 | 0.010 |
Why?
|
Propiophenones | 1 | 1984 | 28 | 0.010 |
Why?
|
Guidelines as Topic | 1 | 2011 | 1399 | 0.010 |
Why?
|
Education, Medical | 1 | 1996 | 1742 | 0.010 |
Why?
|
Atrial Function | 1 | 1984 | 98 | 0.010 |
Why?
|
Animals, Genetically Modified | 1 | 2009 | 1564 | 0.010 |
Why?
|
Coronary Angiography | 4 | 1996 | 4541 | 0.010 |
Why?
|
Monte Carlo Method | 1 | 2010 | 1262 | 0.010 |
Why?
|
Equipment Failure Analysis | 1 | 2007 | 848 | 0.010 |
Why?
|
Insurance, Health | 1 | 1996 | 2518 | 0.010 |
Why?
|
Metoprolol | 1 | 1984 | 90 | 0.010 |
Why?
|
Models, Cardiovascular | 1 | 2009 | 983 | 0.010 |
Why?
|
Timolol | 1 | 1983 | 51 | 0.010 |
Why?
|
Mexiletine | 1 | 1983 | 30 | 0.010 |
Why?
|
Policy Making | 1 | 2007 | 546 | 0.010 |
Why?
|
Electroencephalography | 2 | 2009 | 6317 | 0.010 |
Why?
|
Population Surveillance | 1 | 2013 | 2597 | 0.010 |
Why?
|
Odds Ratio | 1 | 2015 | 9684 | 0.010 |
Why?
|
Rabbits | 1 | 2009 | 4774 | 0.010 |
Why?
|
Administration, Oral | 3 | 1996 | 4040 | 0.010 |
Why?
|
Cardiovascular Agents | 1 | 2009 | 849 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2020 | 22296 | 0.010 |
Why?
|
Propylamines | 1 | 1983 | 161 | 0.010 |
Why?
|
Radionuclide Imaging | 1 | 2006 | 1998 | 0.010 |
Why?
|
Nifedipine | 1 | 1982 | 220 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2018 | 14794 | 0.010 |
Why?
|
Reoperation | 1 | 2012 | 4342 | 0.010 |
Why?
|
Massachusetts | 1 | 2014 | 8894 | 0.010 |
Why?
|
Physical Exertion | 1 | 1983 | 668 | 0.010 |
Why?
|
Health Care Costs | 1 | 2014 | 3270 | 0.010 |
Why?
|
Proteomics | 1 | 2014 | 3914 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2009 | 6512 | 0.010 |
Why?
|
Phlebitis | 1 | 1979 | 35 | 0.010 |
Why?
|
Prostheses and Implants | 1 | 1986 | 1279 | 0.010 |
Why?
|
Enterobacter | 1 | 1978 | 44 | 0.010 |
Why?
|
Staphylococcus | 1 | 1979 | 146 | 0.010 |
Why?
|
Coronary Care Units | 1 | 1980 | 235 | 0.010 |
Why?
|
Pseudomonas | 1 | 1979 | 124 | 0.010 |
Why?
|
Shock | 1 | 1981 | 316 | 0.010 |
Why?
|
Research | 1 | 2007 | 1981 | 0.010 |
Why?
|
Acinetobacter | 1 | 1978 | 39 | 0.010 |
Why?
|
Disease Reservoirs | 1 | 1978 | 123 | 0.010 |
Why?
|
Genomics | 1 | 2014 | 5928 | 0.010 |
Why?
|
Transducers | 1 | 1978 | 245 | 0.010 |
Why?
|
Cineangiography | 1 | 1976 | 108 | 0.010 |
Why?
|
Diarrhea, Infantile | 1 | 1976 | 100 | 0.010 |
Why?
|
Education, Medical, Continuing | 1 | 2001 | 829 | 0.010 |
Why?
|
Candida albicans | 1 | 1979 | 375 | 0.010 |
Why?
|
Peritonitis | 1 | 1978 | 368 | 0.010 |
Why?
|
Angiography | 1 | 1981 | 1598 | 0.010 |
Why?
|
Tachycardia, Ectopic Atrial | 1 | 1996 | 65 | 0.010 |
Why?
|
Enterotoxins | 1 | 1976 | 366 | 0.010 |
Why?
|
Diatrizoate | 1 | 1994 | 81 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2007 | 5544 | 0.010 |
Why?
|
Ischemia | 1 | 1982 | 1900 | 0.010 |
Why?
|
Hypertension | 1 | 2013 | 8617 | 0.010 |
Why?
|
Catheterization | 1 | 1978 | 1431 | 0.010 |
Why?
|
Ultrasonography | 1 | 2006 | 6002 | 0.010 |
Why?
|
Escherichia coli Infections | 1 | 1976 | 524 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2006 | 3538 | 0.010 |
Why?
|
Treatment Failure | 1 | 1997 | 2664 | 0.010 |
Why?
|
Pennsylvania | 1 | 1972 | 615 | 0.010 |
Why?
|
Pyridines | 1 | 1983 | 2895 | 0.010 |
Why?
|
Resuscitation | 2 | 1985 | 679 | 0.010 |
Why?
|
Internal Medicine | 1 | 1997 | 1064 | 0.010 |
Why?
|
Curriculum | 1 | 2001 | 3782 | 0.000 |
Why?
|
Observer Variation | 1 | 1994 | 2623 | 0.000 |
Why?
|
Electrodes | 1 | 1988 | 617 | 0.000 |
Why?
|
Analysis of Variance | 1 | 1994 | 6236 | 0.000 |
Why?
|
Acecainide | 1 | 1984 | 1 | 0.000 |
Why?
|
Propafenone | 1 | 1984 | 27 | 0.000 |
Why?
|
Drug Therapy, Combination | 2 | 1986 | 6320 | 0.000 |
Why?
|
Escherichia coli | 1 | 1976 | 4213 | 0.000 |
Why?
|
Nadolol | 1 | 1983 | 29 | 0.000 |
Why?
|
Purkinje Fibers | 1 | 1983 | 31 | 0.000 |
Why?
|
Ambulatory Care | 2 | 1985 | 2784 | 0.000 |
Why?
|
Wolff-Parkinson-White Syndrome | 1 | 1984 | 117 | 0.000 |
Why?
|
Cardiac Surgical Procedures | 1 | 1978 | 3683 | 0.000 |
Why?
|
Blood Pressure | 1 | 1978 | 8544 | 0.000 |
Why?
|
Photosensitivity Disorders | 1 | 1982 | 79 | 0.000 |
Why?
|
Phenytoin | 1 | 1983 | 189 | 0.000 |
Why?
|
Drug Combinations | 1 | 1988 | 2089 | 0.000 |
Why?
|
Postoperative Care | 1 | 1986 | 1481 | 0.000 |
Why?
|
Pulmonary Fibrosis | 1 | 1982 | 506 | 0.000 |
Why?
|
Data Interpretation, Statistical | 1 | 1988 | 2714 | 0.000 |
Why?
|
Chloramphenicol | 1 | 1976 | 67 | 0.000 |
Why?
|
Drug Resistance | 1 | 1983 | 1599 | 0.000 |
Why?
|
Corneal Diseases | 1 | 1982 | 535 | 0.000 |
Why?
|
Peripheral Nervous System Diseases | 1 | 1982 | 716 | 0.000 |
Why?
|
Colistin | 1 | 1976 | 46 | 0.000 |
Why?
|
Drug Resistance, Microbial | 1 | 1976 | 830 | 0.000 |
Why?
|
Hot Temperature | 1 | 1976 | 1441 | 0.000 |
Why?
|
Software | 1 | 1983 | 4479 | 0.000 |
Why?
|
Mice | 1 | 1985 | 82072 | 0.000 |
Why?
|
Infant | 1 | 1976 | 36556 | 0.000 |
Why?
|
Child | 1 | 1982 | 80960 | 0.000 |
Why?
|